Spire Healthcare Group (LON:SPI – Get Free Report) posted its earnings results on Wednesday. The company reported GBX (0.50) EPS for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a return on equity of 2.22% and a net margin of 1.04%.
Spire Healthcare Group Stock Performance
Shares of Spire Healthcare Group stock traded up GBX 1 on Thursday, reaching GBX 247.50. The stock had a trading volume of 71,514,227 shares, compared to its average volume of 5,796,127. The business’s 50-day moving average price is GBX 238.06 and its two-hundred day moving average price is GBX 207.59. The company has a debt-to-equity ratio of 177.14, a quick ratio of 0.73 and a current ratio of 0.63. Spire Healthcare Group has a fifty-two week low of GBX 140.80 and a fifty-two week high of GBX 249. The stock has a market cap of £991.48 million, a P/E ratio of 61.88, a price-to-earnings-growth ratio of 1.06 and a beta of 0.93.
Analysts Set New Price Targets
Separately, Royal Bank Of Canada cut Spire Healthcare Group to a “sector perform” rating and reduced their price target for the stock from GBX 300 to GBX 250 in a research report on Monday, September 7th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of GBX 247.50.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
Featured Articles
- Five stocks we like better than Spire Healthcare Group
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
